Processa Pharmaceuticals Inc (PCSA)

Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Income/Loss	13.77% -2.8096	-2.4695	-2.1676	-2.7145	-4.1055
Income/Loss From Continuing Operations Before Tax	13.37% -2.7264	-2.4049	-2.082	-2.6126	-4.0221
Income/Loss From Continuing Operations After Tax	13.37% -2.7264	-2.4049	-2.082	-2.6126	-4.0221
Net Income/Loss	13.37% -2.7264	-2.4049	-2.082	-2.6126	-4.0221
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	110.16% 2.4665	-24.27	27.00	26.94	22.77
Diluted Average Shares	110.16% 2.4665	-24.27	27.00	26.94	-2.0708
Basic Earnings Per Share	86.36% -1.11	-8.14	-0.08	-0.10	-0.18
Diluted Earnings Per Share	86.36% -1.11	-8.14	-0.08	-0.10	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-